Ms Sue Williams
Chair, Governance Group, Monash Partners Comprehensive Cancer Consortium, Chief of Health Operations, Cabrini Health
Sue Williams has more than 25 years’ experience in the healthcare industry at senior management level in both the public and private sectors. She commenced her 2 year rotation as MPCCC Chair in May 2016 whilst in her capacity as Chief Executive, Peninsula Health, and joined Cabrini in the new role of Chief of Health Operations in October 2017. Some of Sue’s various roles include Chief Operating Officer of 44 hospitals at Healthscope and the Director of Nursing at the Royal Melbourne Hospital.
Professor Gail Risbridger
Research Director, Monash Comprehensive Cancer Consortium (MCCC) and Monash Partners Comprehensive Cancer Consortium (MPCCC); Head Prostate Cancer Research Group, Monash University
Professor Risbridger played an integral role in the establishment of the Monash Partners Comprehensive Cancer Consortium. She is a National Health and Medical Research Council (NHMRC) research fellow and a career academic and researcher with more than 20 years’ experience in prostate cancer research and men’s health.
Professor Eva Segelov
Acting Clinical Director, Southern Melbourne Integrated Cancer Service, Professor Director of Oncology, Monash Health and Monash University
Professor Eva Segelov is a recognised national and international expert in the fields of gastrointestinal cancer, neuroendocrine tumours, and breast cancer, with a 20 year history of management of patients in a multidisciplinary setting. Professor Segelov has led multiple national and international oncology clinical trials, including investigator-initiated studies. Her research interests relate to translational studies of targeted therapies in defined subpopulations to increase benefit and reduce the toxicity of cancer treatments.
Professor John Zalcberg OAM
Monash Partners Cancer and Blood Diseases Theme representative, Head, Cancer Research Program, School of Public Health and Preventive Medicine, Monash University, Tony Charlton Chair of Oncology, The Alfred
Professor Zalcberg’s clinical research interests include gastrointestinal cancer and health care outcomes. He leads projects in Clinical Quality Registries that collect patient outcome data for lung, ovarian and Upper GI cancers. He has an active involvement in clinical trials in GI cancers and continues an active clinical practice in GI cancer. Professor John Zalcberg was the Director, Division of Cancer Medicine, at the Peter MacCallum Cancer Centre in Melbourne, Australia for 17 years prior to recently taking up the position.